Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q2

9627.TEDINET S100SH2U
Period2023-05-01 → 2023-10-31
Filed2023-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥193.7bn2023-05-01 → 2023-10-31Cons.Net sales
Revenue¥358.7bn2022-05-01 → 2023-04-30Cons.Net sales (5-year summary)
Revenue¥171.2bn2022-05-01 → 2022-10-31Cons.Net sales
Operating income¥8.7bn2023-05-01 → 2023-10-31Cons.Operating income
Operating income¥6.8bn2022-05-01 → 2022-10-31Cons.Operating income
Ordinary income¥9.3bn2023-05-01 → 2023-10-31Cons.Ordinary income
Ordinary income¥17.1bn2022-05-01 → 2023-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.3bn2022-05-01 → 2022-10-31Cons.Ordinary income
Profit before tax¥9.4bn2023-05-01 → 2023-10-31Cons.Income before income taxes
Profit before tax¥7.2bn2022-05-01 → 2022-10-31Cons.Income before income taxes
Net income (owners)¥5.3bn2023-05-01 → 2023-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.2bn2022-05-01 → 2023-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss attributable to owners of parent
Net income¥5.2bn2023-05-01 → 2023-10-31Cons.Profit loss
Net income¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss
Total assets¥242.9bnat 2023-10-31Cons.Assets
Total assets¥231.8bnat 2023-04-30Cons.Assets
Total assets¥231.3bnat 2022-10-31Cons.Total assets (5-year summary)
Total liabilities¥113.1bnat 2023-10-31Cons.Liabilities
Total liabilities¥105.2bnat 2023-04-30Cons.Liabilities
Net assets / equity¥129.8bnat 2023-10-31Cons.Net assets
Net assets / equity¥126.5bnat 2023-04-30Cons.Net assets
Net assets / equity¥120.9bnat 2022-10-31Cons.Net assets (5-year summary)
Cash and deposits¥50.5bnat 2023-10-31Cons.Cash and deposits
Cash and deposits¥46.8bnat 2023-04-30Cons.Cash and deposits
Cash & equivalents¥50.3bnat 2023-10-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2023-04-30Cons.Cash and cash equivalents
Cash & equivalents¥43.5bnat 2022-10-31Cons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30dCons.Cash and cash equivalents
Operating cash flow¥14.1bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥20.3bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥8.5bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥5.8bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥22.3bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18.6bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.2bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥11.2bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.8bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥149.662023-05-01 → 2023-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.732023-08-01 → 2023-10-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥262.872022-05-01 → 2023-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.322022-05-01 → 2022-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.782022-08-01 → 2022-10-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.4%at 2023-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.6%at 2023-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio52.2%at 2022-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue external2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue intersegment2023-05-01 → 2023-10-31¥24m
Otherother segmentssegment ordinary income2023-05-01 → 2023-10-31−¥49m
Reconciling Itemsreconcilingrevenue2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2023-10-31−¥4.4bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥12.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥1.3bn
—segment totalrevenue2023-05-01 → 2023-10-31¥193.8bn
—segment totalrevenue external2023-05-01 → 2023-10-31¥193.7bn
—segment totalrevenue intersegment2023-05-01 → 2023-10-31¥24m
—segment totalsegment ordinary income2023-05-01 → 2023-10-31¥13.8bn
Otherother segmentsrevenue2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue external2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-10-31¥31m
Otherother segmentssegment ordinary income2022-05-01 → 2022-10-31−¥18m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-10-31−¥3.8bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥10.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥349m
—segment totalrevenue2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue external2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue intersegment2022-05-01 → 2022-10-31¥31m
—segment totalsegment ordinary income2022-05-01 → 2022-10-31¥11.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 555
ItemContextValueUnit
Contract liabilitiesPrior1YearInstant532000000JPY
Contract liabilitiesCurrentQuarterInstant456000000JPY
Other clPrior1YearInstant5284000000JPY
Other clCurrentQuarterInstant4444000000JPY
Current liabilitiesPrior1YearInstant92986000000JPY
Current liabilitiesCurrentQuarterInstant102718000000JPY
Long term loans payablePrior1YearInstant5021000000JPY
Long term loans payableCurrentQuarterInstant2996000000JPY
Net defined benefit liabilityPrior1YearInstant4498000000JPY
Net defined benefit liabilityCurrentQuarterInstant4699000000JPY
Other nclPrior1YearInstant2697000000JPY
Other nclCurrentQuarterInstant2662000000JPY
Noncurrent liabilitiesPrior1YearInstant12218000000JPY
Noncurrent liabilitiesCurrentQuarterInstant10359000000JPY
LiabilitiesPrior1YearInstant105204000000JPY
LiabilitiesCurrentQuarterInstant113078000000JPY
Capital stockPrior1YearInstant21894000000JPY
Capital stockCurrentQuarterInstant21894000000JPY
Capital surplusPrior1YearInstant20504000000JPY
Capital surplusCurrentQuarterInstant20499000000JPY
Retained earningsPrior1YearInstant85963000000JPY
Retained earningsCurrentQuarterInstant89113000000JPY
Treasury stockPrior1YearInstant-2000000000JPY
Treasury stockCurrentQuarterInstant-1983000000JPY
Shareholders equityPrior1YearInstant126362000000JPY
Shareholders equityCurrentQuarterInstant129524000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-7000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant156000000JPY
Remeasurements of defined benefit plansPrior1YearInstant95000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant79000000JPY
Valuation and translation adjustmentsPrior1YearInstant87000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant236000000JPY
Non controlling interestsPrior1YearInstant96000000JPY
Non controlling interestsCurrentQuarterInstant83000000JPY
Net assetsPrior1YearInstant126546000000JPY
Net assetsCurrentQuarterInstant129844000000JPY
Liabilities and net assetsPrior1YearInstant231750000000JPY
Liabilities and net assetsCurrentQuarterInstant242922000000JPY
Net salesPrior1YTDDuration171204000000JPY
Net salesCurrentYTDDuration193727000000JPY
Cost of salesPrior1YTDDuration146215000000JPY
Cost of salesCurrentYTDDuration165960000000JPY
Gross profitPrior1YTDDuration24989000000JPY
Gross profitCurrentYTDDuration27767000000JPY
Selling general and administrative expensesPrior1YTDDuration18202000000JPY
Selling general and administrative expensesCurrentYTDDuration19017000000JPY
Operating incomePrior1YTDDuration6786000000JPY
Operating incomeCurrentYTDDuration8749000000JPY
Interest income noiPrior1YTDDuration23000000JPY
Interest income noiCurrentYTDDuration20000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-04-30pass
balance sheet identityconsolidated 2023-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-04-30pass
statement vs summary · net assetsconsolidated 2023-10-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-10-31pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2023-10-31pass
statement vs summary · operating cash flowconsolidated 2022-05-01/2022-10-31pass
statement vs summary · operating cash flowconsolidated 2023-05-01/2023-10-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-10-31pass
statement vs summary · revenueconsolidated 2023-05-01/2023-10-31pass
statement vs summary · total assetsconsolidated 2023-04-30pass
statement vs summary · total assetsconsolidated 2023-10-31pass